TDOC - Teladoc Health, Inc.

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 54.98B
Enterprise Value 34.9B
Trailing P/E N/A
Forward P/E 1-58.59
PEG Ratio (5 yr expected) 1-2.21
Price/Sales (ttm)10.11
Price/Book (mrq)4.96
Enterprise Value/Revenue 39.94
Enterprise Value/EBITDA 6-159.83

Trading Information

Stock Price History

Beta (3Y Monthly) 1.96
52-Week Change 3-8.63%
S&P500 52-Week Change 33.78%
52 Week High 389.05
52 Week Low 342.08
50-Day Moving Average 363.17
200-Day Moving Average 361.19

Share Statistics

Avg Vol (3 month) 31.2M
Avg Vol (10 day) 31.55M
Shares Outstanding 572.04M
Float 71.13M
% Held by Insiders 11.25%
% Held by Institutions 1124.26%
Shares Short (Aug 15, 2019) 422.77M
Short Ratio (Aug 15, 2019) 417.6
Short % of Float (Aug 15, 2019) 432.19%
Short % of Shares Outstanding (Aug 15, 2019) 431.60%
Shares Short (prior month Jul 15, 2019) 420.1M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin -21.85%
Operating Margin (ttm)-14.69%

Management Effectiveness

Return on Assets (ttm)-3.27%
Return on Equity (ttm)-12.65%

Income Statement

Revenue (ttm)492.55M
Revenue Per Share (ttm)7.01
Quarterly Revenue Growth (yoy)37.80%
Gross Profit (ttm)289.17M
EBITDA -30.64M
Net Income Avi to Common (ttm)-107.62M
Diluted EPS (ttm)-1.53
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)472.6M
Total Cash Per Share (mrq)6.56
Total Debt (mrq)458.95M
Total Debt/Equity (mrq)45.77
Current Ratio (mrq)7.56
Book Value Per Share (mrq)13.94

Cash Flow Statement

Operating Cash Flow (ttm)10.91M
Levered Free Cash Flow (ttm)14.66M